Director of Finance, Tom Ford Beauty (FP&A), March 2016 - May 2017Director, Corporate Finance (FP&A), May 2014 - February 2016

Consumer Retail IBD AssociateValuation modeling of DCFs, LBO, Paydown and M&A models Financial analyses examining capital structure, leverage and liquidity Live M&A / buy-side transaction experienceLive debt and equity capital raising experienceCompetitive landscape analyses and exploration of strategic alternativesCompleted rotations through Healthcare, Real Estate and Consumer coverage groups within IBD

Managed day-to-day processes for $5B HCA bond offering;Created pitch books;Calculated diluted shares outstanding at various price targets based on Treasury Stock Method;Prepared Board Presentation materials and valuation analyses for Gilead Sciences' $11B Pharmasset acquisition; Built probability-adjusted Pro Forma Operating Income forecast using proprietary Merger Model;Drafted Contingency Value Rights presentation to prepare senior bankers for Board meeting;Drafted presentations for CEO of $3B Health Services company seeking Board approval to pursue $800M target

Wrote and co-authored over 20 reports advising allocation of Fortune 100 companies' total profits across product-generating assets located in foreign tax jurisdictions to determine global transfer pricing policies;Determined royalty rates for licensing IP assets;Defended my valuation model before IRS; Managed teams of analysts and was primary contact for clients on projects generating $50K-$500K fees;Presented new tax regulations at Knowledge Congress's "Transfer Pricing: Crucial Strategies" webinar;Received 4 promotions within 5 years